92 related articles for article (PubMed ID: 20626289)
1. Th17 cytokines in recall responses against Francisella tularensis in humans.
Paranavitana C; Zelazowska E; DaSilva L; Pittman PR; Nikolich M
J Interferon Cytokine Res; 2010 Jul; 30(7):471-6. PubMed ID: 20626289
[TBL] [Abstract][Full Text] [Related]
2. Lung CD4-CD8- double-negative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain.
Cowley SC; Meierovics AI; Frelinger JA; Iwakura Y; Elkins KL
J Immunol; 2010 May; 184(10):5791-801. PubMed ID: 20393138
[TBL] [Abstract][Full Text] [Related]
3. Signatures of T cells as correlates of immunity to Francisella tularensis.
Eneslätt K; Normark M; Björk R; Rietz C; Zingmark C; Wolfraim LA; Stöven S; Sjöstedt A
PLoS One; 2012; 7(3):e32367. PubMed ID: 22412866
[TBL] [Abstract][Full Text] [Related]
4. IFN-γ, but not IL-17A, is required for survival during secondary pulmonary Francisella tularensis Live Vaccine Stain infection.
Roberts LM; Davies JS; Sempowski GD; Frelinger JA
Vaccine; 2014 Jun; 32(29):3595-603. PubMed ID: 24837506
[TBL] [Abstract][Full Text] [Related]
5. Natural killer and CD8 T cells dominate the response by human peripheral blood mononuclear cells to inactivated Francisella tularensis live vaccine strain.
Gosselin EJ; Gosselin DR; Lotz SA
Hum Immunol; 2005 Oct; 66(10):1039-49. PubMed ID: 16386645
[TBL] [Abstract][Full Text] [Related]
6. Vaccine-Mediated Mechanisms Controlling Replication of
Eneslätt K; Golovliov I; Rydén P; Sjöstedt A
Front Cell Infect Microbiol; 2018; 8():27. PubMed ID: 29468144
[TBL] [Abstract][Full Text] [Related]
7. ESAT-6- and CFP-10-specific Th1, Th22 and Th17 cells in tuberculous pleurisy may contribute to the local immune response against Mycobacterium tuberculosis infection.
Qiao D; Yang BY; Li L; Ma JJ; Zhang XL; Lao SH; Wu CY
Scand J Immunol; 2011 Apr; 73(4):330-7. PubMed ID: 21223348
[TBL] [Abstract][Full Text] [Related]
8. CD4-CD8- T cells control intracellular bacterial infections both in vitro and in vivo.
Cowley SC; Hamilton E; Frelinger JA; Su J; Forman J; Elkins KL
J Exp Med; 2005 Jul; 202(2):309-19. PubMed ID: 16027239
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional profiling of recall responses to Francisella live vaccine strain.
Paranavitana C; DaSilva L; Vladimirova A; Pittman PR; Velauthapillai M; Nikolich M
Pathog Dis; 2014 Mar; 70(2):141-52. PubMed ID: 24453125
[TBL] [Abstract][Full Text] [Related]
10. Multiple T cell subsets control Francisella tularensis LVS intracellular growth without stimulation through macrophage interferon gamma receptors.
Cowley SC; Elkins KL
J Exp Med; 2003 Aug; 198(3):379-89. PubMed ID: 12885873
[TBL] [Abstract][Full Text] [Related]
11. Loss of either CD4+ or CD8+ T cells does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS.
Yee D; Rhinehart-Jones TR; Elkins KL
J Immunol; 1996 Dec; 157(11):5042-8. PubMed ID: 8943413
[TBL] [Abstract][Full Text] [Related]
12. Various membrane proteins of Francisella tularensis induce interferon-gamma production in both CD4+ and CD8+ T cells of primed humans.
Sjöstedt A; Eriksson M; Sandström G; Tärnvik A
Immunology; 1992 Aug; 76(4):584-92. PubMed ID: 1356911
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis.
Lin Y; Ritchea S; Logar A; Slight S; Messmer M; Rangel-Moreno J; Guglani L; Alcorn JF; Strawbridge H; Park SM; Onishi R; Nyugen N; Walter MJ; Pociask D; Randall TD; Gaffen SL; Iwakura Y; Kolls JK; Khader SA
Immunity; 2009 Nov; 31(5):799-810. PubMed ID: 19853481
[TBL] [Abstract][Full Text] [Related]
14. Cytokine response in Balb/c mice infected with Francisella tularensis LVS and the Pohang isolate.
Kim EJ; Park SH; Choi YS; Shim SK; Park MY; Park MS; Hwang KJ
J Vet Sci; 2008 Sep; 9(3):309-15. PubMed ID: 18716452
[TBL] [Abstract][Full Text] [Related]
15. Dominance of human innate immune responses in primary Francisella tularensis live vaccine strain vaccination.
Fuller CL; Brittingham KC; Hepburn MJ; Martin JW; Petitt PL; Pittman PR; Bavari S
J Allergy Clin Immunol; 2006 May; 117(5):1186-8. PubMed ID: 16675351
[No Abstract] [Full Text] [Related]
16. Live vaccine strain Francisella tularensis is detectable at the inoculation site but not in blood after vaccination against tularemia.
Hepburn MJ; Purcell BK; Lawler JV; Coyne SR; Petitt PL; Sellers KD; Norwood DA; Ulrich MP
Clin Infect Dis; 2006 Sep; 43(6):711-6. PubMed ID: 16912944
[TBL] [Abstract][Full Text] [Related]
17. Francisella tularensis-induced in vitro gamma interferon, tumor necrosis factor alpha, and interleukin 2 responses appear within 2 weeks of tularemia vaccination in human beings.
Karttunen R; Surcel HM; Andersson G; Ekre HP; Herva E
J Clin Microbiol; 1991 Apr; 29(4):753-6. PubMed ID: 1909711
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of an outbred mouse model for Francisella tularensis vaccine development and testing.
Sunagar R; Kumar S; Namjoshi P; Rosa SJ; Hazlett KRO; Gosselin EJ
PLoS One; 2018; 13(12):e0207587. PubMed ID: 30533047
[TBL] [Abstract][Full Text] [Related]
19. Specific antibodies protect gamma-irradiated mice against Francisella tularensis infection.
Kubelkova K; Krocova Z; Balonova L; Pejchal J; Stulik J; Macela A
Microb Pathog; 2012; 53(5-6):259-68. PubMed ID: 22841607
[TBL] [Abstract][Full Text] [Related]
20. Critical role for serum opsonins and complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in phagocytosis of Francisella tularensis by human dendritic cells (DC): uptake of Francisella leads to activation of immature DC and intracellular survival of the bacteria.
Ben Nasr A; Haithcoat J; Masterson JE; Gunn JS; Eaves-Pyles T; Klimpel GR
J Leukoc Biol; 2006 Oct; 80(4):774-86. PubMed ID: 16857732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
